Anh Tran
Executive Director, Clinical Operations Late Phase Lead Alexion Pharmaceuticals
Anh Tran is Executive Director, Clinical Operations Late Phase Lead at Alexion Pharmaceuticals, bringing more than two decades of pharmaceutical and clinical operations experience. His career spans leadership roles across late-phase clinical operations, rare disease and neuroscience, including previous senior positions at Pfizer and experience at Bristol Myers Squibb. A PharmD by training, Anh brings extensive expertise across clinical development and late-phase research, with a particular focus on Phase 4 and real-world evidence studies supporting drug development and lifecycle management.
Seminars
Wednesday 24th March 2027
Building an Operational Framework for Post-Trial Access
1:30 pm
- Translating Post-Trial Access strategy into a practical operational framework that can be applied consistently across programs
- Defining the processes, roles and cross-functional responsibilities needed to operationalize Post-Trial Access effectively
- Sharing practical examples and lessons learned from managing Post-Trial Access, including common hurdles and how they have been overcome
- Building a framework that supports consistent decision-making while allowing teams to respond to different program and country requirements
